Jeffrey C. Tatar, RPAC

Jeffrey Tatar practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Jeffrey Tatar's NPI, 1245401348, was assigned on March 17, 2008. Jeffrey Tatar holds New York license 012246.

Jeffrey Tatar's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Jeffrey Tatar's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Jeffrey Tatar is also affiliated with Clifton Springs Hospital and Clinic. The medical group on file is Rochester General Hospital. Dmand AI also links Jeffrey Tatar to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeffrey Tatar practices, 5 sites in all. Vendor and product names are available with a free account.

Physician assistant is Jeffrey Tatar's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Jeffrey Tatar is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Jeffrey Tatar is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, intellectual and developmental disabilities, itchy rashes and joint cyst among the conditions Jeffrey Tatar treats.

CMS data shows 731 Medicare services from Jeffrey Tatar across 11 procedure codes in 2024, for 280 Medicare patients. Medicare paid $28,730 for them. Every service was in an office.

CMS counts 280 Medicare patients who saw Jeffrey Tatar in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jeffrey Tatar's median patient age at 68, with 47% women.

In 2024, Jeffrey Tatar wrote 1,511 Medicare Part D claims for 508 patients. 75% of them were for generic drugs. CMS names the drug for 1,326 of them, across 29 drugs with 11 or more claims each, at $2,433,232 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Jeffrey Tatar for performance year 2024, reported through an alternative payment model (APM). Jeffrey Tatar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Jeffrey Tatar from 8 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $191.